ATE469172T1 - Zellcyclusphasenmarker - Google Patents

Zellcyclusphasenmarker

Info

Publication number
ATE469172T1
ATE469172T1 AT05766537T AT05766537T ATE469172T1 AT E469172 T1 ATE469172 T1 AT E469172T1 AT 05766537 T AT05766537 T AT 05766537T AT 05766537 T AT05766537 T AT 05766537T AT E469172 T1 ATE469172 T1 AT E469172T1
Authority
AT
Austria
Prior art keywords
cell cycle
cycle phase
phase markers
mammalian cell
markers
Prior art date
Application number
AT05766537T
Other languages
English (en)
Inventor
Suzanne Hancock
Simon Stubbs
Nicholas Thomas
Ellen Fanning
Jinming Gu
Original Assignee
Ge Healthcare Uk Ltd
Univ Vanderbilt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare Uk Ltd, Univ Vanderbilt filed Critical Ge Healthcare Uk Ltd
Application granted granted Critical
Publication of ATE469172T1 publication Critical patent/ATE469172T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4738Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/60Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT05766537T 2004-07-23 2005-07-22 Zellcyclusphasenmarker ATE469172T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US59081404P 2004-07-23 2004-07-23
US64596805P 2005-01-21 2005-01-21
US64591505P 2005-01-21 2005-01-21
PCT/GB2005/002884 WO2006008542A1 (en) 2004-07-23 2005-07-22 Cell cycle phase markers

Publications (1)

Publication Number Publication Date
ATE469172T1 true ATE469172T1 (de) 2010-06-15

Family

ID=35229782

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05766537T ATE469172T1 (de) 2004-07-23 2005-07-22 Zellcyclusphasenmarker

Country Status (8)

Country Link
US (3) US20070212707A1 (de)
EP (2) EP1771466B1 (de)
JP (2) JP5080252B2 (de)
AT (1) ATE469172T1 (de)
AU (2) AU2005263988B2 (de)
CA (2) CA2574530A1 (de)
DE (1) DE602005021493D1 (de)
WO (3) WO2006008547A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006008547A1 (en) * 2004-07-23 2006-01-26 Ge Healthcare Uk Limited Cell cycle reporting cell line
US8041090B2 (en) 2005-09-10 2011-10-18 Ge Healthcare Uk Limited Method of, and apparatus and computer software for, performing image processing
JP5408839B2 (ja) * 2006-10-20 2014-02-05 オリンパス株式会社 細胞周期解析方法
CN101659705A (zh) * 2008-08-27 2010-03-03 北京微生物流行病研究所 用于使活细胞中核与染色体成像的融合蛋白
WO2011127170A2 (en) * 2010-04-06 2011-10-13 The Children's Research Institue Methods for diagnosing and treating asthma
US8615164B1 (en) 2010-04-06 2013-12-24 Dominic M. Kotab Systems and methods for operation of recording devices such as digital video recorders (DVRs)
EP2793893A4 (de) 2011-11-23 2015-07-08 Intellikine Llc Verbesserte behandlungspläne unter verwendung von mtor-inhibitoren
WO2022118894A1 (ja) * 2020-12-02 2022-06-09 国立研究開発法人理化学研究所 核可溶性タンパク質の新規分画方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5288641A (en) * 1984-06-04 1994-02-22 Arch Development Corporation Herpes Simplex virus as a vector
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
ES2112211B1 (es) 1996-03-26 1998-12-16 Univ Salamanca Procedimiento para el estudio del ciclo celular de subpoblaciones de celulas presentes en muestras celulares heterogeneas.
US6159691A (en) * 1996-05-15 2000-12-12 Prolifix Limited Assay for a putative regulator of cell cycle progression
US6048693A (en) * 1996-10-16 2000-04-11 Bittech, Inc. Phenotypic assays of cyclin/cyclin-dependent kinase function
CA2278645A1 (en) * 1997-01-23 1998-07-30 The Johns Hopkins University School Of Medicine Characterization of the yeast transcriptome
IL154358A0 (en) * 2000-08-10 2003-09-17 Picower Inst Med Res Treatment of hiv-1 infection and inflammatory disease using cyclophilin receptor antagonists
GB0123856D0 (en) * 2001-10-05 2001-11-28 Amersham Pharm Biotech Uk Ltd Method for determining cell cycle position
JP2004187530A (ja) * 2002-12-09 2004-07-08 Kenji Sugimoto 細胞分裂可視化細胞及びその作製方法、蛍光の検出方法、細胞分裂への影響の評価方法、並びにスクリーニング方法
WO2006008547A1 (en) * 2004-07-23 2006-01-26 Ge Healthcare Uk Limited Cell cycle reporting cell line
US7745123B2 (en) * 2004-07-23 2010-06-29 Ge Healthcare Uk Limited Cell cycle reporting cell line

Also Published As

Publication number Publication date
EP1771465B1 (de) 2012-07-11
AU2005263993B2 (en) 2009-11-12
DE602005021493D1 (de) 2010-07-08
WO2006008547A1 (en) 2006-01-26
CA2574530A1 (en) 2006-01-26
EP1771465A1 (de) 2007-04-11
JP2008511289A (ja) 2008-04-17
WO2006008542A1 (en) 2006-01-26
AU2005263988A1 (en) 2006-01-26
AU2005263993A1 (en) 2006-01-26
AU2005263988B2 (en) 2009-10-01
US7612189B2 (en) 2009-11-03
EP1771466A1 (de) 2007-04-11
JP2008507265A (ja) 2008-03-13
US20070212707A1 (en) 2007-09-13
WO2006008539A1 (en) 2006-01-26
EP1771466B1 (de) 2010-05-26
JP5143552B2 (ja) 2013-02-13
US20070264681A1 (en) 2007-11-15
US7897741B2 (en) 2011-03-01
CA2574540A1 (en) 2006-01-26
JP5080252B2 (ja) 2012-11-21
US20100028899A1 (en) 2010-02-04

Similar Documents

Publication Publication Date Title
ATE469172T1 (de) Zellcyclusphasenmarker
EA201291024A1 (ru) Композиции эндорибонуклеаз и способы их использования
TR201806812T4 (tr) Rna-yönlendirmeli hedef dna modifikasyonu için ve rna-yönlendirmeli transkripsiyon modifikasyonu için yöntemler ve bileşimler.
ATE544071T1 (de) Fluoreszenzpolarisationstests für die acetyltransferase-deacetylase-aktivität
ATE480643T1 (de) Homogener nachweis von analyten
GT200800132A (es) Anticuerpos anti-il-23 humanos, composiciones, metodos y usos
BR112012031071A2 (pt) 8-proteínas de ligação à il-1
DE60328383D1 (de) Zusammensetzungen zur zuführung von nukleinsäuren an zellen
WO2011163423A3 (en) Methods and compositions for cell permeable stat3 inhibitor
DE60144015D1 (de) Modifizierte embryonale stammzellen und embryonales stammzellspezifisches gen
CL2008002917A1 (es) Anticuerpos especificos para 5-ennolpiruvilshikimato-3-fosfato sintetasa (epsps) doble mutante; hibridoma productor; método para generar dichos anticuerpos; eodo de detección de dicha enzima epsps doble mutante en una composición; kit para detectar la presencia de dicha epsps doble mutante en la composición.
BR112012026379A2 (pt) métodos para gerar proteína endogenamente marcada
ATE443775T1 (de) Hif-prolylhydroxylase-aktivitätstest
WO2011031497A3 (en) Quantitative fluorescent protein standards
DK1994149T3 (da) Nye fluorescerende proteiner og fremgangsmåder til anvendelse deraf
RU2009108662A (ru) Способ выявления остеогенных средств и способ стимуляции остеогенеза (варианты)
DK2069512T3 (da) Acetolaktat-syntase fra Trichoderma reesei som selektionsmarkør
TR201903573T4 (tr) Npp1 füzyon protei̇nleri̇.
WO2009093242A3 (en) Cell populations for polypeptide analysis and uses of same
WO2007052102A3 (en) Modified green fluorescent proteins and methods for using same
ECSP077240A (es) Variantes mejoradas de la aprotinina
ATE539163T1 (de) Auf der verwendung von mva beruhende impfstoffe
EP1934606A4 (de) Optimierte trpm8-nukleinsäuresequenzen und ihre verwendung bei zellbasierten tests sowie testkits zur identifizierung von trpm8-modulatoren
WO2007123636A9 (en) Compositions and methods comprising the use of cell surface displayed homing endonucleases
ATE414701T1 (de) Fluoreszenzsonden zur verwendung bei einem bindungsassay auf proteinkinaseinhibitoren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties